SSRIs: the first six weeks

If you're about to start an SSRI for depression or anxiety, the most important thing you can know is that the first six weeks may feel worse before they feel better. Not for everyone, but for enough patients that not warning you about it is doing you a disservice.

What's happening biologically

SSRIs (selective serotonin reuptake inhibitors) work by blocking the reabsorption of serotonin in the synaptic cleft, which increases the amount of serotonin available to bind to receptors. The benefit shows up not from that immediate increase, but from the downstream adaptations: receptor density changes, new neural connections forming, and (the most current model) increased neuroplasticity in mood-regulating circuits.

That downstream cascade takes 4-6 weeks for most patients. The early side effects, by contrast, are largely driven by the immediate serotonin surge in places you don't want it (the gut, mainly).

The week-by-week pattern

Week 1: Nausea, sometimes mild headaches, vivid dreams or sleep disruption. Some patients notice an increase in anxiety in the first 7-10 days — this is the most counterintuitive side effect and the one most likely to cause people to quit. It's real, it's predictable, and it typically resolves by week 3.

Weeks 2-3: The nausea usually lifts. Sleep starts to normalize. The anxiety bump (if you had one) starts to subside. You probably still don't feel "better" yet. This is the hardest stretch psychologically because you're past the side-effect peak but you haven't yet hit the therapeutic effect.

Weeks 3-4: First signs of benefit. Patients often describe it as the volume getting turned down — the catastrophizing background chatter quiets, the ruminative loops shorten, sleep onset gets easier.

Weeks 4-6: The full therapeutic effect starts showing up. This is when a patient who came in saying "I can't focus, I'm exhausted, everything feels heavy" often comes back saying "I had a good week. I don't know if it's the medication or just a good week."

Week 6 onwards: If you're not seeing meaningful benefit by week 8 at therapeutic dose, that's a signal to either titrate up or switch — not a reason to keep waiting indefinitely.

What "therapeutic dose" actually means

A lot of patients quit SSRIs at week 4 because the low starting dose didn't move the needle. The starting dose is a tolerability dose, not a therapeutic one. Most SSRIs need to be titrated up over the first 2-4 weeks to reach a dose that's actually expected to work:

• Sertraline: typically start 25mg, target 50-200mg
• Escitalopram: typically start 5mg, target 10-20mg
• Fluoxetine: typically start 10mg, target 20-60mg

If you're at the bottom of that range and feeling no benefit by week 4-6, the move is usually upward, not outward.

The honest disclaimer about therapy

SSRIs are not a substitute for therapy. They work with therapy, and the combination is consistently better than either alone for moderate-to-severe presentations. The medication raises your floor — it gives you the energy and emotional bandwidth to actually do the cognitive work. Treating the SSRI as the whole solution is the most common reason patients have to switch medications or escalate doses repeatedly.

When to message your clinician early

• Suicidal thoughts that are new or escalating (especially in the first 2 weeks; this is a known and tracked adverse effect, particularly in patients under 25)
• Severe agitation or restlessness (akathisia) that doesn't resolve within 5-7 days
• Any sign of serotonin syndrome (rare but serious): high fever, severe muscle stiffness, confusion, rapid heart rate — especially if you're on other serotonergic drugs

These aren't reasons to "tough it out." They're reasons to talk to a clinician promptly so we can adjust.

Editorial content on a Relyv.ai demonstration site. Fictional author. Not medical advice.